Literature DB >> 10448186

HFE gene mutation and transferrin saturation in very low birthweight infants.

R F Maier1, H Witt, C Bührer, E Mönch, E Köttgen.   

Abstract

AIM: To determine if there is an association between high transferrin saturation and the C282Y HFE gene mutation in very low birthweight (VLBW) infants.
METHODS: One hundred and forty three VLBW infants receiving recombinant erythropoietin and 3 to 9 mg/kg/day of enteral iron were studied. Genomic DNA was extracted from filter paper cards. The C282Y mutation was determined by restriction fragment length polymorphism analysis.
RESULTS: Six infants were heterozygous for the mutation; none was homozygous. Ten infants had a transferrin saturation above 80% at least once. No infant was positive for both transferrin saturation above 80% and the mutation.
CONCLUSIONS: The data strongly suggest that there is no association between high transferrin saturation and the HFE gene mutation in VLBW infants during the first weeks of life.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448186      PMCID: PMC1720994          DOI: 10.1136/fn.81.2.f144

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  6 in total

1.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

3.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

Authors:  C Q Edwards; L M Griffen; D Goldgar; C Drummond; M H Skolnick; J P Kushner
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

4.  High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group.

Authors:  R F Maier; M Obladen; E Kattner; J Natzschka; J Messer; B M Regazzoni; C P Speer; V Fellman; E L Grauel; P Groneck; M Wagner; G Moriette; B L Salle; G Verellen; P Scigalla
Journal:  J Pediatr       Date:  1998-05       Impact factor: 4.406

5.  Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

Authors:  Z J Bulaj; L M Griffen; L B Jorde; C Q Edwards; J P Kushner
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

Review 6.  Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes.

Authors:  C Q Edwards; L M Griffen; J Kaplan; J P Kushner
Journal:  J Intern Med       Date:  1989-11       Impact factor: 8.989

  6 in total
  1 in total

1.  HFE gene variants modify the association between maternal lead burden and infant birthweight: a prospective birth cohort study in Mexico City, Mexico.

Authors:  David Cantonwine; Howard Hu; Martha Maria Téllez-Rojo; Brisa N Sánchez; Héctor Lamadrid-Figueroa; Adrienne S Ettinger; Adriana Mercado-García; Mauricio Hernández-Avila; Robert O Wright
Journal:  Environ Health       Date:  2010-07-26       Impact factor: 5.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.